Insight Molecular Diagnostics Ord Shs
IMDX7.320USD
+0.630+9.42%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
209.53MMarket Cap
LossP/E TTM
More Details of Company
Insight Molecular Diagnostics Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Insight Molecular Diagnostics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Chairman of the Board
Chairman of the Board
152.16K
+55000.00%
Dr. Andrew J. Last
Dr. Andrew J. Last
Independent Director
Independent Director
39.51K
+35000.00%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
36.56K
+35000.00%
Mr. Joshua Riggs
Mr. Joshua Riggs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.50K
--
Mr. James Liu, CPA
Mr. James Liu, CPA
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
--
--
Dr. Ekkehard Schuetz, M.D., Ph.D.
Dr. Ekkehard Schuetz, M.D., Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Ms. Andrea S. James
Ms. Andrea S. James
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Chairman of the Board
Chairman of the Board
152.16K
+55000.00%
Dr. Andrew J. Last
Dr. Andrew J. Last
Independent Director
Independent Director
39.51K
+35000.00%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
36.56K
+35000.00%
Mr. Joshua Riggs
Mr. Joshua Riggs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.50K
--
Mr. James Liu, CPA
Mr. James Liu, CPA
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
--
--
Dr. Ekkehard Schuetz, M.D., Ph.D.
Dr. Ekkehard Schuetz, M.D., Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Pharma Services
260.00K
0.00%
By RegionUSD
Name
Revenue
Proportion
United States Pharma services
260.00K
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pharma Services
260.00K
0.00%
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Broadwood Capital, Inc.
39.81%
Smith (Patrick W)
11.37%
AWM Investment Company, Inc.
9.85%
Bio Rad Laboratories Inc
9.64%
Pura Vida Investments, LLC
3.30%
Other
26.03%
Shareholders
Shareholders
Proportion
Broadwood Capital, Inc.
39.81%
Smith (Patrick W)
11.37%
AWM Investment Company, Inc.
9.85%
Bio Rad Laboratories Inc
9.64%
Pura Vida Investments, LLC
3.30%
Other
26.03%
Shareholder Types
Shareholders
Proportion
Hedge Fund
43.49%
Individual Investor
12.91%
Investment Advisor/Hedge Fund
10.95%
Corporation
9.64%
Investment Advisor
2.49%
Other
20.52%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
44
16.28M
56.94%
--
2025Q4
59
16.33M
56.98%
-21.02K
2025Q3
63
16.26M
56.74%
-114.67K
2025Q2
76
16.21M
8.76%
+317.02K
2025Q1
86
16.10M
56.30%
+2.27M
2024Q4
89
8.43M
48.30%
-193.34K
2024Q3
99
7.19M
53.72%
-268.68K
2024Q2
118
7.51M
59.43%
+222.34K
2024Q1
152
4.82M
59.90%
+9.71K
2023Q4
161
4.90M
60.95%
-7.78K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Broadwood Capital, Inc.
11.41M
39.81%
--
--
Sep 30, 2025
Smith (Patrick W)
3.26M
11.37%
--
--
May 12, 2025
AWM Investment Company, Inc.
2.82M
9.85%
--
--
Sep 30, 2025
Bio Rad Laboratories Inc
2.76M
9.64%
+1.25M
+82.94%
Feb 10, 2025
Pura Vida Investments, LLC
947.13K
3.3%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
486.74K
1.7%
+2.97K
+0.61%
Sep 30, 2025
Geode Capital Management, L.L.C.
198.45K
0.69%
+40.87K
+25.94%
Sep 30, 2025
James (Andrea S.)
239.06K
0.83%
+87.83K
+58.07%
Oct 31, 2025
Arno (Andrew)
152.16K
0.53%
+55.00K
+56.61%
Jul 01, 2025
BlackRock Institutional Trust Company, N.A.
85.62K
0.3%
+1.45K
+1.73%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Small Cap Value ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Micro-Cap ETF
Proportion0.01%
DFA Dimensional US Small Cap Value ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Jul 24, 2023
Merger
20→1
Date
Ex-dividend Date
Type
Ratio
Jul 24, 2023
Merger
20→1
